Six-Year Retention Rates with Abatacept Vs TNF Inhibitors in the Treatment of Rheumatoid Arthritis: Experience from the Real-World Rhumadata Clinical Database and Registry

被引：0

作者：

Choquette, Denis ^{[1
]}

Bessette, Louis ^{[2
]}

Haraoui, Boulos ^{[3
]}

Raynauld, Jean-Pierre ^{[1
]}

Sauvageau, Diane ^{[1
]}

Turcotte, Angele ^{[4
]}

Villeneuve, Edith ^{[1
]}

Coupal, Louis ^{[1
]}

机构：

[1] IRRM, Rheumatol, Montreal, PQ, Canada

[2] CORQ, Quebec City, PQ, Canada

[3] Univ Montreal, Montreal, PQ, Canada

[4] CORQ, Rheumatol, Quebec City, PQ, Canada

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

488

引用

页数：3

共 50 条

[1] Six-Year Retention Rates with Abatacept vs TNF inhibitors in the Treatment of Rheumatoid Arthritis: Experience from the Real-world Rhumadata Clinical Database and Registry
Choquette, Denis
Bessette, Louis
Haraoui, Boulos
Raynauld, Jean-Pierre
Sauvageau, Diane
Turcotte, Angele
Villeneuve, Edith
Massicotte, Frederic
Brown, Jacques
Coupal, Louis
[J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1211 - 1212
[2] Retention Rates of TNF Inhibitors and Abatacept Used as a First Biologic DMARD in the Treatment of Rheumatoid Arthritis: 8 Years of Experience from the Rhumadata® Registry
Choquette, Denis
Bessette, Louis
Alemao, Evo
Haraoui, Boulos
Massicotte, Frederic
Mtibaa, Mondher
Muratti, Eleonora
Pelletier, Jean-Pierre
Postema, Roelien
Raynauld, Jean-Pierre
Remillard, Marie-Anais
Sauvageau, Diane
Turcotte, Angele
Villeneuve, Edith
Coupal, Louis
[J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1053 - 1053
[3] RETENTION RATES OF TNF INHIBITORS AND ABATACEPT USED AS A FIRST BIOLOGIC DMARD IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 8 YEARS OF EXPERIENCE FROM THE RHUMADATA® REGISTRY
Choquette, D.
Bessette, L.
Alemao, E.
Haraoui, B.
Massicotte, F.
Mtibaa, M.
Muratti, E.
Pelletier, J-P.
Postema, R.
Raynauld, J-P.
Remillard, M-A.
Sauvageau, D.
Turcotte, A.
Villeneuve, E.
Coupal, L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 571 - 572
[4] Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
Denis Choquette
Louis Bessette
Evo Alemao
Boulos Haraoui
Roelien Postema
Jean-Pierre Raynauld
Louis Coupal
[J]. Arthritis Research & Therapy, 21
[5] Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9years of experience from the Rhumadata® clinical database and registry
Choquette, Denis
Bessette, Louis
Alemao, Evo
Haraoui, Boulos
Postema, Roelien
Raynauld, Jean-Pierre
Coupal, Louis
[J]. ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
[6] Abatacept Shows Better Sustainability than TNF Inhibitors when Used Following Initial Biologic DMARD Failure in the Treatment of Rheumatoid Arthritis: 8 Years of Real-World Observations from the Rhumadata® Clinical Database and Registry
Choquette, Denis
Bessette, Louis
Alemao, Evo
Haraoui, Boulos
Massicotte, Frederic
Mtibaa, Mondher
Muratti, Eleonora
Pelletier, Jean-Pierre
Postema, Roelien
Raynauld, Jean-Pierre
Remillard, Marie-Anais
Sauvageau, Diane
Turcotte, Angele
Villeneuve, Edith
Coupal, Louis
[J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1053 - 1053
[7] ABATACEPT SHOWS BETTER SUSTAINABILITY THAN TNF INHIBITORS WHEN USED FOLLOWING INITIAL BIOLOGIC DMARD FAILURE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 8 YEARS OF REAL-WORLD OBSERVATIONS FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
Choquette, D.
Bessette, L.
Alemao, E.
Haraoui, B.
Massicotte, F.
Mtibaa, M.
Muratti, E.
Pelletier, J-P.
Postema, R.
Raynauld, J-P.
Remillard, M-A.
Sauvageau, D.
Turcotte, A.
Villeneuve, E.
Coupal, L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1188 - 1188
[8] Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras - Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®
Choquette, Denis
Bessette, Louis
Coupal, Louis
Garces, Kirsten
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[9] Disease and Treatment Characteristics That Might Influence Long-Term Retention with Biologics in the Real-World Clinical Setting: Experience from the Rhumadata Clinical Database and Registry
Choquette, Denis
Bessette, Louis
Haraoui, Boulos
Raynauld, Jean-Pierre
Sauvageau, Diane
Turcotte, Angele
Villeneuve, Edith
Coupal, Louis
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[10] Disease and Treatment Characteristics that Might Influence Long-term Retention with Biologics in the Real-world Clinical Setting: Experience from the Rhumadata Clinical Database and Registry
Choquette, Denis
Bessette, Louis
Haraoui, Boulos
Raynauld, Jean-Pierre
Sauvageau, Diane
Turcotte, Angele
Villeneuve, Edith
Massicotte, Frederic
Brown, Jacques
Coupal, Louis
[J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1212 - 1212

← 1 2 3 4 5 →